Locations
Barcelona, Spain · Sant Celoni, Barcelona, Spain
industry
Biotechnology · Consumer Products · DeepTech · Hardware · Health
Size
51-200 employees
Stage
Series B
founded in
2019
INBRAIN Neuroelectronics is pioneering breakthrough neuroelectronic therapies that combine hardware and data analytics to decode and modulate neural networks. Their innovative platform features skin-like, bi-directional brain-computer interfaces (BCI) with high resolution, enabling real-time smart neural decoding and modulation. The company has received FDA Breakthrough Device Designation for its technology aimed at treating Parkinson’s Disease. By harnessing the potential of graphene, INBRAIN is developing safe, scalable therapies that promise to revolutionize the treatment of neural disorders, addressing a significant market need and positioning itself as a leader in the neurotechnology space.
Something looks off?On-site & Remote